De Ying Cao
Direttore/Membro del Consiglio presso HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Posizioni attive di De Ying Cao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 30/12/2021 | - |
| Independent Dir/Board Member | 30/12/2021 | - | |
| Hebei Medical University | Corporate Officer/Principal | 08/08/2011 | - |
Hebei Yipin Pharmaceutical Co., Ltd.
 Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Direttore/Membro del Consiglio | 01/05/2021 | - |
| Independent Dir/Board Member | 01/05/2021 | - |
Storia della carriera di De Ying Cao
Precedenti posizioni note di De Ying Cao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 08/08/2011 | - |
| Independent Dir/Board Member | 08/08/2011 | - |
Statistiche
Distribuzione geografica
| Cina | 4 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
- Borsa valori
- Insiders
- De Ying Cao
- Esperienza
